The Latest in Leukemia, Myelodysplasia, Transplantation

Predicting therapy-related myeloid neoplasms

December 13, 2016

Agent exhibits activity in relapsed/refractory AML

December 10, 2016

EC grants venetoclax conditional approval for CLL

December 9, 2016

Drug produces responses in ‘challenging’ patients

December 9, 2016

Data suggest one BTK inhibitor could replace another

December 8, 2016

Group estimates global cancer cases, deaths in 2015

December 8, 2016

Half of CML patients can stop TKI therapy, study suggests

December 7, 2016

Combo shows early promise in newly diagnosed AML

December 6, 2016

NCCN releases new guidelines for cancer patients

December 1, 2016

FDA grants full approval for ponatinib

November 30, 2016

NICE recommends taking ibrutinib off CDF

November 30, 2016

Decitabine produces responses in high-risk MDS, AML

November 29, 2016

CAR T-cell trial placed on hold again

November 25, 2016

EC grants drug orphan status for AML, sarcoma

November 24, 2016

EC expands indication for arsenic trioxide in APL

November 23, 2016

Leukemia, Myelodysplasia, Transplantation